C/EBPβ deficiency has been shown to inhibit CCl4-induced liver fibrosis [148]; however, other reports have shown that C/EBPβ protein levels or DNA binding activity increase in models of liver fibrosis induced by CCl4 [73, 149, 150]. Here, CEBPB is linked to Hepatic fibrosis.